KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Medpace Holdings (MEDP) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $123.3 million.

  • Medpace Holdings' Accumulated Depreciation & Amortization rose 2468.22% to $123.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $123.3 million, marking a year-over-year increase of 2468.22%. This contributed to the annual value of $123.3 million for FY2025, which is 2468.22% up from last year.
  • Medpace Holdings' Accumulated Depreciation & Amortization amounted to $123.3 million in Q4 2025, which was up 2468.22% from $98.9 million recorded in Q4 2024.
  • In the past 5 years, Medpace Holdings' Accumulated Depreciation & Amortization ranged from a high of $123.3 million in Q4 2025 and a low of $51.1 million during Q4 2021
  • For the 5-year period, Medpace Holdings' Accumulated Depreciation & Amortization averaged around $83.0 million, with its median value being $79.4 million (2023).
  • In the last 5 years, Medpace Holdings' Accumulated Depreciation & Amortization soared by 3066.64% in 2021 and then soared by 2155.54% in 2022.
  • Over the past 5 years, Medpace Holdings' Accumulated Depreciation & Amortization (Quarter) stood at $51.1 million in 2021, then grew by 21.56% to $62.1 million in 2022, then grew by 27.83% to $79.4 million in 2023, then increased by 24.51% to $98.9 million in 2024, then grew by 24.68% to $123.3 million in 2025.
  • Its Accumulated Depreciation & Amortization stands at $123.3 million for Q4 2025, versus $98.9 million for Q4 2024 and $79.4 million for Q4 2023.